Ibritumomab

A4DAB139 | Approved
MS4A1/CD20
G1 / None
Biogen Schering Spectrum Pharmaceuticals
Approved
Whole mAb
BAY86-5128 IDEC-129 IDEC 129 IDEC129 SH-L-749 Zevalin Zevamab
7.1
IMGT PubChem (46506112) PubChem (135305414) PubChem (319416193) PubChem (385637780) PubChem (405469868) PubChem (440016529) PubChem (446242497) PubChem (461827117) PubChem (471080662) PubChem (472220715) PubChem (485987002) Thera-SAbDab YAbS
Avg A4D Score
-0.6649
Score Range
-0.66
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB139_3bky_H_L 3bky 100% -0.6649 6.5 9.0 -0.1647 -0.7263